These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


187 related items for PubMed ID: 15852200

  • 41. Estrogen, inflammation and cardiovascular risk in women: a critical appraisal.
    Störk S, van der Schouw YT, Grobbee DE, Bots ML.
    Trends Endocrinol Metab; 2004 Mar; 15(2):66-72. PubMed ID: 15036252
    [Abstract] [Full Text] [Related]

  • 42. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA, Blake JM, Crosignani PG.
    Hum Reprod Update; 2005 Mar; 11(6):545-60. PubMed ID: 16150813
    [Abstract] [Full Text] [Related]

  • 43. Coronary heart disease of females: lessons learned from nonhuman primates.
    Clarkson TB, Mehaffey MH.
    Am J Primatol; 2009 Sep; 71(9):785-93. PubMed ID: 19382155
    [Abstract] [Full Text] [Related]

  • 44. WHI risks: any relevance to menopause management?
    Burger HG.
    Maturitas; 2007 May 20; 57(1):6-10. PubMed ID: 17368974
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Cardiovascular disease as a current threat of older women. Relation to estrogens].
    Zárate A, Saucedo R, Basurto L, Martínez C.
    Ginecol Obstet Mex; 2007 May 20; 75(5):286-92. PubMed ID: 17849811
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article.
    Lakoski SG, Herrington DM.
    Climacteric; 2005 Dec 20; 8(4):317-26. PubMed ID: 16390766
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Cardiovascular health and the menopause: the gynecologist as the patients' interface.
    Arias RD.
    Climacteric; 2006 Sep 20; 9 Suppl 1():6-12. PubMed ID: 16899438
    [Abstract] [Full Text] [Related]

  • 53. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A, Aldemir DA, Bayrak T, Corakçi A, Dursun P.
    Arch Gynecol Obstet; 2006 Aug 20; 274(5):289-96. PubMed ID: 16810536
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [The effectiveness of estrogen replacement therapy to reduce ischemic heart disease--revaluation].
    Ben-Chetrit A, Zacut D, Shimonovitz S.
    Harefuah; 2003 Jan 20; 142(1):32-7, 78. PubMed ID: 12647487
    [Abstract] [Full Text] [Related]

  • 57. B-type natriuretic peptide after hormone therapy in postmenopausal women with chest pain and normal coronary angiogram.
    Kawano H, Nagayoshi Y, Soejima H, Tanaka Y, Hokamaki J, Miyamoto S, Miyazaki Y, Yamabe H, Ogawa H.
    Menopause; 2008 Jan 20; 15(2):352-6. PubMed ID: 18090872
    [Abstract] [Full Text] [Related]

  • 58. Postmenopausal hormone therapy in clinical perspective.
    Hodis HN, Mack WJ.
    Menopause; 2007 Jan 20; 14(5):944-57. PubMed ID: 17353803
    [Abstract] [Full Text] [Related]

  • 59. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 20; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 60. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review.
    Sherwin BB, Henry JF.
    Front Neuroendocrinol; 2008 Jan 20; 29(1):88-113. PubMed ID: 17980408
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.